Table 3:

Details of mutations identified in patients with a positive molecular diagnosis

Trio*SexAffected geneInheritanceMutation typeNCBI RefSeqcDNA and protein changes identifiedMolecular diagnosis (OMIM no.)
2MACECompound heterozygousFrameshift deletionNM_000789.3c.819_820delAG; p.(Arg274Glyfs*117)Renal tubular dysgenesis (106180)
Frameshift deletionNM_000789.3c.3521delG; p.(Gly1174Alafs*12)
6MSCN1ADe novoMissenseNM_001202435.1c.620T>G; p.(Val207Gly)SCN1A-related encephalopathy syndrome (607208)
8MMTM1X-linkedNonsenseNM_000252.2c.584C>A; p.(Tyr198*)Myotubular myopathy, X-linked (310400)
9FFTOAutosomal recessiveMissenseNM_001080432.2c.956C>T; p.(Ser319Phe)FTO deficiency syndrome (612938)
11MWDR19Compound heterozygousNonsenseNM_025132.3c.1600G>T; p.(Glu534*)Cranioectodermal dysplasia (614376)
MissenseNM_025132.3c.2129T>C; p.(Leu710Ser)
15MCHRNDAutosomal recessiveSplice siteNM_000751.2c.932+5G>A; p.?Congenital myasthenic syndrome (601462)
18MDYRK1ADe novoSplice siteNM_001396.3c.951+4_951+7delAGTA; p.?Autosomal dominant intellectual disability syndrome type 7 (614104)
19FWT1De novoMissenseNM_024426.4c.1460A>C; p.(His469Pro)Denys–Drash syndrome (194080)
  • Note: cDNA = complementary DNA, NCBI = National Center for Biotechnology Information (US), OMIM = Online Mendelian Inheritance in Man.

  • * Trio = newborn + parents.